Health / Medical Topics

    Cantuzumab Ravtansine

    Definition 1

    An immunotoxin of a humanized monoclonal antibody C242 (MoAb HuC242) conjugated to a derivative of the cytotoxic agent maytansine, DM4, with potential antitumor activity. Cantuzumab ravtansine is generated from MoAb C242, which is raised against a cell surface superantigen, CA242, found in a variety of human tumor cells. Upon binding and entry, the immunoconjugate releases the maytansinoid agent DM4, which binds to tubulin, thereby affecting microtubule assembly/disassembly dynamics. As a result, this agent prevents cell division and reduces cell growth of cancer cells that express CA242. (NCI Thesaurus)

    Definition 2

    A substance being studied in the treatment of some types of cancer. It is made by linking the monoclonal antibody huC242 to a toxic substance called maytansinoid DM4. The monoclonal antibody binds to the surfaces of cancer cells and the maytansinoid DM4 enters the cells and blocks their growth. It is a type of immunotoxin. (NCI Dictionary)




    YOU MAY ALSO LIKE

    A liquid that has been promoted as a treatment for a wide range of diseases, including cancer. The ingredients thought to be…
    A small administrative division of a country.
    Source: National Cancer Institute (U.S.)
    Carotenoid having a chemical structure similar to beta-carotene with carbonyl (C=O) functions at the number 4 and 4' carbon atoms.
    Human CANT1 wild-type allele is located in the vicinity of 17q25.3 and is approximately 18 kb in length. This allele, which encodes…
    This gene plays a role in both nucleotide hydrolysis and signal transduction.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact